Martingale Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Martingale Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,908	Closed	-$533K	–	1106
2020 Q3	$533K	Buy	3,908 +201	+5%	+$21.4K	0.01%	797
2020 Q2	$359K	Buy	+3,707	New	+$309K	﹤0.01%	926
2018 Q2	–	Sell	-17,013	Closed	-$831K	–	1030
2018 Q1	$831K	Sell	17,013 -2,203	-11%	-$115K	0.01%	754
2017 Q4	$809K	Buy	19,216 +7	+0%	+$270	0.01%	737
2017 Q3	$824K	Sell	19,209 -13,191	-41%	-$421K	0.01%	771
2017 Q2	$425K	Buy	+32,400	New	+$427K	0.01%	846

Martingale Asset Management's MYOK Position: Q4 2020 in Review

Martingale Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 3,908 shares — an estimated $533K sold.

Martingale Asset Management first reported a position in MYOK in Q2 2017 and held it in 6 quarters. The position peaked at $831K in Q1 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Martingale Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Martingale Asset Management sold 3,908 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $533K.
Martingale Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
Martingale Asset Management's MyoKardia, Inc. Common Stock position peaked at $831K in Q1 2018.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.